ArticleOpen forum infectious diseases2023

Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study.

Mireille Mpoudi-Etame et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.